The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
Open accessAbstract
Resistance of solid tumors to treatment is significantly attributed to pharmacokinetic reasons at both cellular and multi-cellular levels. Anticancer agent must be bio-available at the site of action in a cytotoxic concentration to exert its proposed activity. P-glycoprotein (P-gp) is a member of the ATP-dependent membrane transport proteins; it is known to pump substrates out of cells in ATP-dependent mechanism. The over-expression of P-gp in tumor cells reduces the intracellular drug concentrations, which decreases the cytotoxicity of a broad spectrum of antitumor drugs. Accordingly, P-gp inhibitors/blockers are potential enhancer for the cellular bioavailability of several clinically important anticancer drugs such as, anthracyclines, taxanes, vinca alkaloids, and podophyllotoxins. Besides several chemically synthesized P-gp inhibitors/blockers, some naturally occurring compounds and plant extracts were reported for their modulation of multidrug resistance; however, this review will focus only on major classes of naturally occurring inhibitors viz., flavonoids, coumarins, terpenoids, alkaloids and saponins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells
Ikeda, R., Che, X., Yamaguchi, T., Ushiyama, M., Zheng, C., Okumura, H., Takeda, Y., Shibayama, Y., Nakamura, K. T., Jeung, H., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00057.x · Cited by 2,272
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1981) · PubMed · Cited by 1,459
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Is the multidrug transporter a flippase?
Higgins, C. F., & Gottesman, M. M. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90419-a · Cited by 722
Reduced permeability in CHO cells as a mechanism of resistance to colchicine
Ling, V., & Thompson, L. H. (1974) · Journal of Cellular Physiology · doi:10.1002/jcp.1040830114 · Cited by 686
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1982) · PubMed · Cited by 659
Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
Jonker, J. W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1651 · Cited by 638
Hyafil, F., Pauwels-Vergely, C., Vignaud, P. D., & Grand‐Perret, T. (1993) · PubMed · Cited by 525
Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D., & Fiere, D. (1992) · Blood · doi:10.1182/blood.v79.2.473.473 · Cited by 487
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C., Ruevekamp, M. C., Floot, B. G., & Schellens, J. H. M. (1999) · PubMed · Cited by 487
Legault, J., & Pichette, A. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.12.0005 · Cited by 452
Boesch, D., Gavériaux‐Ruff, C., Jachez, B., Pourtier, A., Bollinger, P., & Loor, F. (1991) · PubMed · Cited by 360
Cornwell, M. M., Safa, A. R., Felsted, R. L., Gottesman, M. M., & Pastan, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.3847 · Cited by 338
Dantzig, A. H., Shepard, R. L., Cao, J., Law, K. L., Ehlhardt, W. J., Baughman, T. M., Bumol, T. F., & Starling, J. J. (1996) · PubMed · Cited by 328
Zhang, S., & Morris, M. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044412 · Cited by 309
Safa, A. R., Glover, C. J., Meyers, M. B., Biedler, J. L., & Felsted, R. L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84537-4 · Cited by 287
Arceci, R. J., Croop, J. M., Horwitz, S. B., & Housman, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4350 · Cited by 265
Sharom, F. J., Yu, X., & Doige, C. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80510-9 · Cited by 256
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
Ross, D. D., Karp, J. E., Chen, T. T., & Doyle, L. A. (2000) · Blood · doi:10.1182/blood.v96.1.365 · Cited by 250
Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells
Kawabata, S., Oka, M., Shiozawa, K., Tsukamoto, K., Nakatomi, K., Soda, H., Fukuda, M., Ikegami, Y., Sugahara, K., Yamada, Y., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4267 · Cited by 242
Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy
Bansal, T., Jaggi, M., Khar, R., & Talegaonkar, S. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3rc77 · Cited by 238
Chearwae, W., Anuchapreeda, S., Nandigama, K., Ambudkar, S. V., & Limtrakul, P. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.009 · Cited by 229
Young, L. C., Campling, B. G., Cole, S. P. C., Deeley, R. G., & Gerlach, J. H. (2001) · PubMed · Cited by 220
Choi, J.-S., Piao, Y.-J., & Kang, K. W. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0411-x · Cited by 206
Characterization of the ATPase Activity of Purified Chinese Hamster P-glycoprotein
Urbatsch, I. L., Al-Shawi, M. K., & Senior, A. E. (1994) · Biochemistry · doi:10.1021/bi00189a008 · Cited by 205
Horio, M., Chin, K. V., Currier, S. J., Goldenberg, S., Williams, C., Pastan, I., Gottesman, M. M., & Handler, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63784-6 · Cited by 196
P-glycoprotein, multidrug resistance and tumor progression
Bradley, G., & Ling, V. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689638 · Cited by 195
Pick, A., Müller, H., Mayer, R., Haenisch, B., Pajeva, I. K., Weigt, M., Bönisch, H., Müller, C. E., & Wiese, M. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.043 · Cited by 192
Newman, M. J., Rodarte, J. C., Benbatoul, K. D., Romano, S. J., Zhang, C., Krane, S., Moran, E. J., Uyeda, R. T., Dixon, R., Guns, E. S. T., et al. (2000) · PubMed · Cited by 190
Kannan, P., Telu, S., Shukla, S., Ambudkar, S. V., Pike, V. W., Halldin, C., Gottesman, M. M., Innis, R. B., & Hall, M. D. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn100078a · Cited by 181
Zeng, H., Bain, L. J., Belinsky, M. G., & Kruh, G. D. (1999) · PubMed · Cited by 173
Ohnishi, A., Matsuo, H., Yamada, S., Takanaga, H., Morimoto, S., Shoyama, Y., Ohtani, H., & Sawada, Y. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703433 · Cited by 158
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
Holland, M. L., Panetta, J. A., Hoskins, J. M., Bebawy, M., Roufogalis, B. D., Allen, J. D., & Arnold, J. C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.033 · Cited by 157
Lum, B. L., & Gosland, M. P. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30097-2 · Cited by 156
Höll, V., Kouba, M., Dietel, M., & Vogt, G. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90149-d · Cited by 131
Effect of Flavonoids on MRP1-Mediated Transport in Panc-1 Cells
Nguyen, H. T. T., Zhang, S., & Morris, M. E. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10283 · Cited by 131
Roepe, P. D., Li, W., Cruz, J., & Carlson, D. (1993) · Biochemistry · doi:10.1021/bi00092a014 · Cited by 127
(-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line
Farabegoli, F., Papi, A., Bartolini, G., Ostan, R., & Orlandi, M. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.01.001 · Cited by 123
Risinger, A. L., Jackson, E. M., Polin, L., Helms, G. L., LeBoeuf, D. A., Joe, P. A., Hopper-Borge, E. A., Ludueña, R. F., Kruh, G. D., & Mooberry, S. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2037 · Cited by 123
In vitro effect of quercetin on human gastric carcinoma: Targeting cancer cells death and MDR
Borska, S., Chmielewska, M., Wysocka, T., Drąg‐Zalesińska, M., Zabel, M., & Dzięgiel, P. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.06.035 · Cited by 122
Zhang, S., & Morris, M. E. (2003) · Pharmaceutical Research · doi:10.1023/a:1025044913766 · Cited by 120
Choi, C.-H., Kang, G. J., & Min, Y. (2003) · Planta Medica · doi:10.1055/s-2003-38483 · Cited by 116
Roepe, P. D. (1992) · Biochemistry · doi:10.1021/bi00165a003 · Cited by 112
Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters
Eid, S. Y., El-Readi, M. Z., & Wink, M. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.05.010 · Cited by 110
Min, Y. D., Kwon, H. C., Yang, M. C., Lee, K. H., Choi, S. U., & Lee, K. R. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02977779 · Cited by 108
Mullin, S., Mani, N., & Grossman, T. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4171-4176.2004 · Cited by 105
P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs
Eichhorn, T., & Efferth, T. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.08.053 · Cited by 101
Molnar, J. A., Gyémánt, N., Tanaka, M., Hohmann, J., Bergmann‐Leitner, E. S., Molnár, P., Deli, J., Didiziapetris, R., & Ferreira, M. U. (2005) · Current Pharmaceutical Design · doi:10.2174/138161206775201893 · Cited by 99
Sen, R., Natarajan, K., Bhullar, J., Shukla, S., Fang, H.-B., Cai, L., Chen, Z., Ambudkar, S. V., & Baer, M. R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0302 · Cited by 93
Spoelstra, E. C., Dekker, H., Schuurhuis, G. J., Broxterman, H. J., & Lankelma, J. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90531-9 · Cited by 91
Lai, K., Kuo, C., Ho, H.-C., Yang, J., Ma, C.-Y., Lu, H.-F., Huang, H.-Y., Chueh, F., Yu, C.-C., & Chung, J. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.02.004 · Cited by 90
Al-Abd, A. M., Mahmoud, A. M., El-Sherbiny, G. A., El‐Moselhy, M. A., Nofal, S. M., El-Latif, H. A. A., El‐Eraky, W. I., & El‐Shemy, H. A. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00783.x · Cited by 90
Self-citationJatrophane diterpenes from Euphorbia spp. as modulators of multidrug resistance in cancer therapy
Corea, G., Pietro, A. D., Dumontet, C., Fattorusso, E., & Lanzotti, V. (2009) · Phytochemistry Reviews · doi:10.1007/s11101-009-9126-8 · Cited by 80
Huang, X., Xiao, X., Zhang, Y., Talele, T. T., Salim, A. A., Chen, Z., & Capon, R. J. (2014) · Marine Drugs · doi:10.3390/md12073818 · Cited by 79
Differential expression of P‐glycoprotein genes in primary rat hepatocyte culture
Lee, C. H., Bradley, G., Zhang, J., & Ling, V. W. T. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570223 · Cited by 78
SUN, L., Chen, W., Qu, L., Wu, J., & Jin, S. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1742 · Cited by 77
Duarte, N., Varga, A., Черепнев, Г. В., Radics, R., Molnar, J. A., & Ferreira, M. U. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.028 · Cited by 76
Ma, Y., & Wink, M. (2008) · Phytomedicine · doi:10.1016/j.phymed.2007.11.028 · Cited by 75
Effects of Kaempferia Parviflora Extracts and Their Flavone Constituents on P-glycoprotein Function
Patanasethanont, D., Nagai, J., Yumoto, R., Murakami, T., Sutthanut, K., Sripanidkulchai, B., Yenjai, C., & Takano, M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20769 · Cited by 71
Lei, Y., Tan, J., Wink, M., Ma, Y., Li, N., & Su, G. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.09.059 · Cited by 70
Romiti, N., Tramonti, G., Donati, A., & Chieli, E. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.015 · Cited by 68
Silva, G. L., Cui, B., Chávez, D., You, M., Chai, H., Rasoanaivo, P., Lynn, S. M., O’Neill, M. J., Lewis, J. A., Besterman, J. M., et al. (2001) · Journal of Natural Products · doi:10.1021/np010295+ · Cited by 64
Louisa, M., Soediro, T. M., & Suyatna, F. D. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.4.1639 · Cited by 64
Kim, M. K., Choo, H., & Chong, Y. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500290c · Cited by 63
Sugawara, I., Nakahama, M., Hamada, H., TSURUO, T., & Mori, S. (1988) · PubMed · Cited by 62
Li, C., Kim, M.-H., Choi, H.-S., & Choi, J. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-1117-9 · Cited by 60
Kimura, S. H., Ito, C., Jyoko, N., Segawa, H., Kuroda, J., Okada, M., Adachi, S., Nakahata, T., Yuasa, T., Filho, V. C., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20505 · Cited by 59
Xiang, Q., Zhang, D., Wang, J., Zhang, H., Zheng, Z., Yu, D., Li, Y., Xu, J. H., Chen, Y., & Shang, C. (2014) · Liver International · doi:10.1111/liv.12524 · Cited by 54
Saab, A. M., Guerrini, A., Sacchetti, G., Maietti, S., Zeino, M., Arend, J., Gambari, R., Bernardi, F., & Efferth, T. (2012) · Planta Medica · doi:10.1055/s-0032-1327896 · Cited by 53
Dale, I., Tuffley, W., Callaghan, R., Holmes, J. A., Martin, K., Luscombe, M., Mistry, P., Ryder, H., Stewart, A. J., Charlton, P., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.597 · Cited by 52
Shen, X., Chen, G., Zhu, G., & Fong, W. F. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.06.066 · Cited by 48
Tenacigenin B Derivatives Reverse P-Glycoprotein-Mediated Multidrug Resistance inHepG2/Dox Cells
Hu, Y., Shen, X., Lu, H.-L., et al. (2008) · Journal of Natural Products · doi:10.1021/np070458f · Cited by 48
Cortés-Selva, F., Jiménez, I. A., Muñoz‐Martínez, F., Campillo, M., Bazzocchi, I. L., Pardo, L., RAVELO, A. G., Castanys, S., & Gamarro, F. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054864920 · Cited by 47
Lee, E., Enomoto, R., Koshiba, C., & Hirano, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04722.x · Cited by 45
Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
Kessel, D. H., & Wilberding, C. (1985) · PubMed · Cited by 44
Reyes, C. P., Muñoz‐Martínez, F., Torrecillas, I. R., Mendoza, C. R., Gamarro, F., Bazzocchi, I. L., Nuñez, M. J., Pardo, L., Castanys, S., Campillo, M., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070290v · Cited by 42
Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla
Nguyen, V. T. B., Darbour, N., Bayet, C., Doreau, A., Raad, I., Phung, B. H., Dumontet, C., Pietro, A. D., Dijoux‐Franca, M., & Guilet, D. (2008) · Fitoterapia · doi:10.1016/j.fitote.2008.09.010 · Cited by 41
Polyphenols Counteract Tumor Cell Chemoresistance Conferred by Multidrug Resistance Proteins
Michalak, K., & Wesołowska, O. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012802650011 · Cited by 36
Romiti, N., Pellati, F., Nieri, P., Benvenuti, S., Adinolfi, B., & Chieli, E. (2008) · Planta Medica · doi:10.1055/s-2008-1034308 · Cited by 33
SDZ PSC-833—a novel potent in vitro chemosensitizer in multiple myeloma
Jönsson, B., Nilsson, K., Nygren, P., & Larsson, R. (1992) · Anti-Cancer Drugs · doi:10.1097/00001813-199212000-00013 · Cited by 31
Tran, T. T. P., Kim, H. G., Choi, J. H., Na, M., & Jeong, H. G. (2013) · Phytomedicine · doi:10.1016/j.phymed.2013.01.014 · Cited by 27
Modulating Drug Resistance by Targeting BCRP/ABCG2 Using Retrovirus-Mediated RNA Interference
Xie, N., Mou, L., Yuan, J., Liu, W., Deng, T., Li, Z., Jin, Y., & Hu, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103463 · Cited by 22
Ferreira, M. U., Gyémánt, N., Madureira, A., et al. (2005) · PubMed · Cited by 18
Reversal of Multidrug Resistance by Kopsiflorine Isolated from Kopsia dasyrachis
Rho, M., Toyoshima, M., Hayashi, M., et al. (1999) · Planta Medica · doi:10.1055/s-1999-13991 · Cited by 17
Inhibition of P-glycoprotein by two artemisinin derivatives
Steglich, B., Mahringer, A., Li, Y., et al. (2012) · Natural Products and Bioprospecting · doi:10.1007/s13659-012-0006-3 · Cited by 13
Cited by
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.010 · Cited by 729
Metal–Organic Framework Nanocarriers for Drug Delivery in Biomedical Applications
Sun, Y., Zheng, L., Yang, Y., Qian, X., Fu, T., Li, X., Yang, Z., Yan, H., Cui, C., & Tan, W. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00423-3 · Cited by 723
El-Sawy, H. S., Al-Abd, A. M., Ahmed, T. A., El-Say, K. M., & Torchilin, V. P. (2018) · ACS Nano · doi:10.1021/acsnano.8b06104 · Cited by 431
Self-citationRecent discoveries of anticancer flavonoids
Raffa, D., Maggio, B., Raimondi, M. V., Plescia, F., & Daidone, G. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.034 · Cited by 339
Duan, C., Yu, M., Xu, J., Li, B.-Y., Zhao, Y., & Kankala, R. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114643 · Cited by 335
Metadata
- Authors
- Abdallah, H. M., Al-Abd, A. M., El-Dine, R. S., & El-Halawany, A. M.
- Venue
- Journal of Advanced Research
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 6
- Issue
- 1
- Pages
- 45-62
- ISSN
- 2090-1224 (ISSN-L)
- 2090-1232
- OpenAlex
- W2051446073
- Cited by
- 319
- References
- 90
- FWCI
- 12.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.